Cloopen Group Holding Limited Sponsored ADR RAAS
1.13
0.00
0.00%
as of 11 Jun
- Market cap
- $121.2M
- P/E
- 0.0×
Follow RAAS
| Older periods | Mar '21 | Jun '21 | Sep '21 | Dec '21 | |
|---|---|---|---|---|---|
P/E ratio |
+3 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 3.31 | 1.63 | 1.21 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(52.61) | (48.74) | (26.62) | (3.81) | |
P/B ratio |
1.17 | 1.07 | 0.54 | 0.39 | |
Price to Tangible BV |
1.25 | 1.14 | 0.58 | 0.43 | |
EV/Sales |
0.00 | 0.71 | (0.67) | (1.96) | |
EV/EBITDA |
0.00 | 0.00 | 6.51 | 1.62 | |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 2.40 | |
EV/FCF |
0.00 | 0.00 | 0.00 | 2.32 | |
Quick Ratio |
4.80 | 4.69 | 6.77 | 3.64 | |
Current Ratio |
5.08 | 4.98 | 7.22 | 3.87 | |
Net Debt/EBITDA |
18.45 | 25.48 | 22.42 | 4.30 | |
Debt/Assets |
0.58% | 6.55% | 0.00% | 0.45% | |
Debt/Equity |
0.01 | 0.08 | 0.00 | 0.01 | |
Asset Turnover |
— | 0.44 | 0.50 | 0.38 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.08 | |
Capex/Depreciation |
— | — | — | (0.82) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
33.58% | 22.63% | 27.36% | 917.73% | |
Selling, General and Administrative Expense of Revenue |
82.76% | 55.68% | 58.76% | 2,034.59% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 2,690.80% | |
Graham Net Nets |
0.77 | 0.85 | 1.66 | 2.19 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(100.95%) | (551.46%) | (1,061.63%) | (1,618.07%) | |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | (69.91%) | |
Revenue per Share |
0.85 | 0.77 | 0.74 | 0.03 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | (0.76) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.03) | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (0.79) | |
Cash per Share |
11.60 | 7.56 | 7.10 | 7.65 | |
Shareholders Equity per Share |
11.69 | 7.95 | 8.15 | 7.36 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.69 | 7.95 | 8.15 | 7.36 | |
Free Cash Flow |
— | — | — | (38.71) | |
Working Capital |
392.43 | 402.27 | 428.52 | 315.46 | |
Capital Expenditures |
— | — | — | (1.35) | |
Net Current Asset Value |
387.36 | 397.63 | 424.29 | 312.29 | |
EV/EBIT |
0.00 | 0.00 | 6.37 | 1.62 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.84 | |
Net Profit Margin |
(1,375.41%) | (38.93%) | (40.38%) | (27,437.92%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 45.18 | 45.98 | 31.22 | |
Average Payables |
— | 22.37 | 23.11 | 21.70 | |
Average Assets |
— | 320.89 | 310.41 | 311.65 | |
Average Common Equity |
— | 126.70 | 119.54 | (179.55) |
Columns are period end dates